Christopher Landeg
Geschäftsführer bei Quotient Sciences (Reading) Ltd.
Aktive Positionen von Christopher Landeg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Quotient Sciences (Reading) Ltd.
 Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
| Geschäftsführer | - | - |
Karriereverlauf von Christopher Landeg
Statistik
International
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Quotient Sciences (Reading) Ltd.
Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Christopher Landeg
- Erfahrung
